These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 8851606
1. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Rabin L, Hincenbergs M, Moreno MB, Warren S, Linquist V, Datema R, Charpiot B, Seifert J, Kaneshima H, McCune JM. Antimicrob Agents Chemother; 1996 Mar; 40(3):755-62. PubMed ID: 8851606 [Abstract] [Full Text] [Related]
2. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Pettoello-Mantovani M, Kollmann TR, Raker C, Kim A, Yurasov S, Tudor R, Wiltshire H, Goldstein H. Antimicrob Agents Chemother; 1997 Sep; 41(9):1880-7. PubMed ID: 9303378 [Abstract] [Full Text] [Related]
4. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. Kollmann TR, Kim A, Pettoello-Mantovani M, Hachamovitch M, Rubinstein A, Goldstein MM, Goldstein H. J Immunol; 1995 Jan 15; 154(2):907-21. PubMed ID: 7814892 [Abstract] [Full Text] [Related]
5. Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals. Stoddart CA, Bales CA, Bare JC, Chkhenkeli G, Galkina SA, Kinkade AN, Moreno ME, Rivera JM, Ronquillo RE, Sloan B, Black PL. PLoS One; 2007 Aug 01; 2(7):e655. PubMed ID: 17668043 [Abstract] [Full Text] [Related]
6. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. Pettoello-Mantovani M, Kollmann TR, Katopodis NF, Raker C, Kim A, Yurasov S, Wiltshire H, Goldstein H. J Infect Dis; 1998 Feb 01; 177(2):337-46. PubMed ID: 9466519 [Abstract] [Full Text] [Related]
7. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. Kollmann TR, Pettoello-Mantovani M, Zhuang X, Kim A, Hachamovitch M, Smarnworawong P, Rubinstein A, Goldstein H. J Exp Med; 1994 Feb 01; 179(2):513-22. PubMed ID: 8294863 [Abstract] [Full Text] [Related]
8. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Withers-Ward ES, Amado RG, Koka PS, Jamieson BD, Kaplan AH, Chen IS, Zack JA. Nat Med; 1997 Oct 01; 3(10):1102-9. PubMed ID: 9334721 [Abstract] [Full Text] [Related]
9. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model. Honeycutt JB, Wahl A, Archin N, Choudhary S, Margolis D, Garcia JV. Retrovirology; 2013 Oct 24; 10():121. PubMed ID: 24156277 [Abstract] [Full Text] [Related]
10. Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1. Gobbi A, Stoddart CA, Locatelli G, Santoro F, Bare C, Linquist-Stepps V, Moreno ME, Abbey NW, Herndier BG, Malnati MS, McCune JM, Lusso P. J Virol; 2000 Sep 24; 74(18):8726-31. PubMed ID: 10954574 [Abstract] [Full Text] [Related]
12. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Kaneshima H, Shih CC, Namikawa R, Rabin L, Outzen H, Machado SG, McCune JM. Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4523-7. PubMed ID: 1903543 [Abstract] [Full Text] [Related]
13. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct 01; 10(2):139-49. PubMed ID: 7552477 [Abstract] [Full Text] [Related]
14. Simple i.v. inoculation of HIV-1 to Thy/Liv SCID-hu mice induce reproducible HIV infection with narrowing of medulla in human thymic implant. Okamoto Y, Ogura A, Shibata S, Amagai T, Katsura Y, Asano T, Honda M. J Vet Med Sci; 1997 Apr 01; 59(4):259-63. PubMed ID: 9152933 [Abstract] [Full Text] [Related]
15. Development of a human thymic organ culture model for the study of HIV pathogenesis. Bonyhadi ML, Su L, Auten J, McCune JM, Kaneshima H. AIDS Res Hum Retroviruses; 1995 Sep 01; 11(9):1073-80. PubMed ID: 8554904 [Abstract] [Full Text] [Related]
16. Suppression of HIV infection in AZT-treated SCID-hu mice. McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H. Science; 1990 Feb 02; 247(4942):564-6. PubMed ID: 2300816 [Abstract] [Full Text] [Related]
17. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC. J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895 [Abstract] [Full Text] [Related]
18. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, Cort S, Sullivan JL. N Engl J Med; 1997 May 08; 336(19):1343-9. PubMed ID: 9134874 [Abstract] [Full Text] [Related]
19. HIV-1-associated pathology in hemato-lymphoid organs and the experimental evaluation in the SCID-hu mouse. Kaneshima H. Int J Hematol; 1996 Jun 08; 63(4):253-64. PubMed ID: 8762809 [Abstract] [Full Text] [Related]
20. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Datema R, Rabin L, Hincenbergs M, Moreno MB, Warren S, Linquist V, Rosenwirth B, Seifert J, McCune JM. Antimicrob Agents Chemother; 1996 Mar 08; 40(3):750-4. PubMed ID: 8851605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]